Exercise and Inflammation in Pediatric Crohn's Disease

被引:41
|
作者
Ploeger, H. [1 ]
Obeid, J. [1 ]
Nguyen, T. [1 ]
Takken, T. [2 ]
Issenman, R.
de Greef, M. [3 ]
Timmons, B. [1 ,2 ]
机构
[1] McMaster Univ, Child Hlth & Exercise Med Program, Hamilton, ON L8N 3Z5, Canada
[2] UMC Utrecht, Child Dev & Exercise Ctr, Utrecht, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
基金
加拿大自然科学与工程研究理事会;
关键词
children; cycle ergometry; cytokines; growth factors; inflammatory bowel disease; BOWEL-DISEASE; GROWTH MEDIATORS; CYTOKINES; CHILDREN; INTERLEUKIN-6; CELLS; EPIDEMIOLOGY; POPULATION; FITNESS; MARKERS;
D O I
10.1055/s-0032-1304323
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
We examined inflammatory cells, cytokines and growth factors in response to acute bouts of moderate intensity continuous exercise and high intensity intermittent exercise in youth with Crohn's disease and in healthy matched-controls. 15 patients and 15 controls performed 30 min of cycling at 50% of peak mechanical power (PMP) and 6 bouts of 4 x 15-s of cycling at 100% PMP. Blood was collected at rest, at the mid-point, at the end of exercise and at 30 and 60 min into recovery. In patients with CD, both types of exercise increased immune cells and GH and decreased IGF-I. Moderate intensity exercise induced a greater increase in leukocytes (p < 0.05), neutrophils (p < 0.05), lymphocytes (p < 0.001), monocytes (p < 0.05), IL-6 (p < 0.05), IL-17 (p < 0.05) and GH (p < 0.05) and a similar decrease in IGF- I, compared with high intensity exercise. TNF-alpha did not change signifi cantly with either exercise. Responses in patients were similar compared with controls; however, in patients monocytes remained elevated signifi cantly longer in response to MICE. Youth with Crohn's disease can engage in distinctly diff erent types of exercise without a signifi cant acute exacerbation of infl ammation.
引用
收藏
页码:671 / 679
页数:9
相关论文
共 50 条
  • [31] The pharmacotherapeutic management of pediatric Crohn?s disease
    Zimmerman, Lori
    Bousvaros, Athos
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (17) : 2161 - 2168
  • [32] The use of infliximab in pediatric Crohn's Disease
    Khan, S
    Henderson, WA
    Kocoshis, SA
    Goyal, A
    Di Lorenzo, C
    GASTROENTEROLOGY, 2001, 120 (05) : A210 - A210
  • [33] Infliximab therapy for pediatric Crohn's disease
    Veres, Gabor
    Baldassano, Robert N.
    Mamula, Petar
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) : 1869 - 1880
  • [34] Infliximab therapy for pediatric Crohn's disease
    Oliva-Hemker, M
    Roper, S
    Cuffari, C
    Lake, A
    Wilson, L
    Leibowitz, I
    Duffy, L
    Tuchman, D
    GASTROENTEROLOGY, 2002, 122 (04) : A612 - A613
  • [35] Adalimumab for the treatment of pediatric Crohn's disease
    Nuti, Federica
    Fiorino, Gionata
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (09) : 963 - 972
  • [36] Menarche in Pediatric Patients with Crohn’s Disease
    Neera Gupta
    Robert H. Lustig
    Michael A. Kohn
    Eric Vittinghoff
    Digestive Diseases and Sciences, 2012, 57 : 2975 - 2981
  • [37] SLEEP PATTERNS IN PEDIATRIC CROHN'S DISEASE
    Winberry, Gabriel B.
    Razafindrarivo, Faniry
    Douglas, Leslie
    Sidamo, Amanuel
    Slaughter, James C.
    Malow, Beth
    Buchowski, Maciej
    Acra, Sari
    GASTROENTEROLOGY, 2017, 152 (05) : S432 - S433
  • [38] Cutaneous Crohn's Disease in the Pediatric Population
    Vaid, Reena Moza
    Cohen, Bernard A.
    PEDIATRIC DERMATOLOGY, 2010, 27 (03) : 279 - 281
  • [39] Perioperative Management of Pediatric Crohn's Disease
    Pasternak, Brad
    Patel, Ashish
    Tran, Paul
    McMahon, Lisa
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (02): : 137 - 141
  • [40] Menarche in Pediatric Patients with Crohn's Disease
    Gupta, Neera
    Lustig, Robert H.
    Kohn, Michael A.
    Vittinghoff, Eric
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (11) : 2975 - 2981